Gufic Biosciences Limited — Others, 16-11-2024: Copy of Newspaper Publication

Gufic Biosciences has published its unaudited financial results for the quarter and half-year ended September 30, 2024. The total income from operations stands at ₹4,892 crore, while the net loss after tax (post exceptional items) is recorded at ₹596 crore. The company continues to grapple with profitability, evident from a significant loss in the prior periods as well.

The financial results suggest ongoing challenges, impacting Gufic's operational efficiency and raising concerns among investors. However, the stability of its equity share capital at ₹6,525 crore indicates a solid base for future strategic initiatives. Investor sentiment may remain cautious due to these losses, but opportunities for recovery could emerge as the company navigates these financial hurdles.